June Carl H, Maus Marcela V, Plesa Gabriela, Johnson Laura A, Zhao Yangbing, Levine Bruce L, Grupp Stephan A, Porter David L
Abramson Cancer Center, University of Pennsylvania, 3400 Civic Center Boulevard, 8th Floor, Philadelphia, PA, 19104-5156, USA,
Cancer Immunol Immunother. 2014 Sep;63(9):969-75. doi: 10.1007/s00262-014-1568-1. Epub 2014 Jun 19.
It is now well established that the immune system can control and eliminate cancer cells. Adoptive T cell transfer has the potential to overcome the significant limitations associated with vaccine-based strategies in patients who are often immune compromised. Application of the emerging discipline of synthetic biology to cancer, which combines elements of genetic engineering and molecular biology to create new biological structures with enhanced functionalities, is the subject of this focused research review.
现在已经充分证实，免疫系统能够控制并消除癌细胞。在通常免疫功能受损的患者中，过继性T细胞转移有可能克服与基于疫苗的策略相关的重大局限性。合成生物学这一新兴学科在癌症领域的应用，即将基因工程和分子生物学元素结合起来以创造具有增强功能的新生物结构，是本重点研究综述的主题。
